A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be ...

Efficacy and safety of intramuscular (IM) recombinant Erwinia asparaginase in acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): The Children’s Oncology Group (COG) AALL1931 study.

The treatment of leukemia among children could be made more precise with fewer side effects with the help of more accurate ...

Using the National Cancer Database, this retrospective cohort study identified 23,397 ALL patients between the ages of 0-18 who received chemotherapy from 2004-2020. Patients with race listed as ...

More information: Mats Jerkeman et al, Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden, Leukemia (2025).

A new study has revealed that a “common” ingredient found in a string of popular energy drinks could elevate the risk of blood cancers. US researchers have found that taurine, an amino acid ...